Long Noncoding RNAs in the Pathogenesis of Barrett's Esophagus and Esophageal Carcinoma

Gastroenterology

Volumn 153, Issue 1, 2017, Pages 27-34

  Abraham, John M ^a   Meltzer, Stephen J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Barrett's Esophagus; Esophageal Carcinoma; lncRNAs

Indexed keywords

ENHANCER RNA; LONG UNTRANSLATED RNA; PROTEIN P53; RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

AUTOREGULATION; BARRETT ESOPHAGUS; CHROMOSOME; ESOPHAGUS CARCINOMA; GENE; GENETIC CODE; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; DNA METHYLATION; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; PRECANCER;

BARRETT ESOPHAGUS; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PRECANCEROUS CONDITIONS; RNA, LONG NONCODING;

EID: 85033672543     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2017.04.046     Document Type: Review

References (74)

1. Badillo, R., Francis, D., Diagnosis and treatment of gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther 5 (2014), 105–112.
2. Sappati Biyyani, R.S., Chak, A., Barrett's esophagus: review of diagnosis and treatment. Gastroenterol Rep (Oxf) 1 (2013), 9–18.
3. Modiano, N., Gerson, L.B., Barrett's esophagus: incidence, etiology, pathophysiology, prevention and treatment. Ther Clin Risk Manag 3 (2007), 1035–1145.
4. Cancer Genome Atlas Research Network, Analysis Working Group: Asan University, BC Cancer Agency, et al. Integrated genomic characterization of oesophageal carcinoma. Nature 541 (2017), 169–175.
5. Choi, Y.S., Patena, W., Leavitt, A.D., et al. Widespread RNA 3′-end oligouridylation in mammals. RNA 18 (2012), 394–401.
6. Quaresma, A.J., Sievert, R., Nickerson, J.A., Regulation of mRNA export by the PI3 kinase/AKT signal transduction pathway. Mol Biol Cell 24 (2013), 1208–1221.
7. Cech, T.R., Steitz, J.A., The noncoding RNA revolution-trashing old rules to forge new ones. Cell 157 (2014), 77–94.
8. Quinn, J.J., Chang, H.Y., Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet 17 (2016), 47–62.
9. Busch, H., Reddy, R., Rothblum, L., et al. SnRNAs, SnRNPs, and RNA processing. Annu Rev Biochem 51 (1982), 617–654.
10. Wahl, M.C., Will, C.L., Luhrmann, R., The spliceosome: design principles of a dynamic RNP machine. Cell 136 (2009), 701–718.
11. Liu, J., Maxwell, E.S., Mouse U14 snRNA is encoded in an intron of the mouse cognate hsc70 heat shock gene. Nucleic Acids Res 18 (1990), 6565–6571.
12. Lee, R.C., Feinbaum, R.L., Ambros, V., The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993), 843–854.
13. Wightman, B., Ha, I., Ruvkun, G., Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75 (1993), 855–862.
14. Lagos-Quintana, M., Rauhut, R., Lendeckel, W., et al. Identification of novel genes coding for small expressed RNAs. Science 294 (2001), 853–858.
15. Gurtan, A.M., Sharp, P.A., The role of miRNAs in regulating gene expression networks. J Mol Biol 425 (2013), 3582–3600.
16. Keniry, A., Oxley, D., Monnier, P., et al. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol 14 (2012), 659–665.
17. Dey, B.K., Pfeifer, K., Dutta, A., The H19 long noncoding RNA gives rise to microRNAs miR-675–3p and miR-675–5p to promote skeletal muscle differentiation and regeneration. Genes Dev 28 (2014), 491–501.
18. Bansal, A., Gupta, V., Wang, K., MicroRNA expression signatures during malignant progression from Barrett's esophagus. J Cell Biochem 117 (2016), 1288–1295.
19. Mallick, R., Patnaik, S.K., Wani, S., et al. A systematic review of esophageal MicroRNA markers for diagnosis and monitoring of Barrett's esophagus. Dig Dis Sci 61 (2016), 1039–1050.
20. Bus, P., Kestens, C., Ten Kate, F.J., et al. Profiling of circulating microRNAs in patients with Barrett's esophagus and esophageal adenocarcinoma. J Gastroenterol 51 (2016), 560–570.
21. Greider, C.W., Blackburn, E.H., A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337 (1989), 331–337.
22. Fatica, A., Bozzoni, I., Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet 15 (2014), 7–21.
23. Shlyueva, D., Stampfel, G., Stark, A., Transcriptional enhancers: from properties to genome-wide predictions. Nat Rev Genet 15 (2014), 272–286.
24. Trimarchi, T., Bilal, E., Ntziachristos, P., et al. Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia. Cell 158 (2014), 593–606.
25. Zhang, Y., Tycko, B., Monoallelic expression of the human H19 gene. Nat Genet 1 (1992), 40–44.
26. Adalsteinsson, B.T., Ferguson-Smith, A.C., Epigenetic control of the genome—lessons from genomic imprinting. Genes (Basel) 5 (2014), 635–655.
27. Royo, H., Cavaille, J., Non-coding RNAs in imprinted gene clusters. Biol Cell 100 (2008), 149–166.
28. Mancini-Dinardo, D., Steele, S.J., Levorse, J.M., et al. Elongation of the Kcnq1ot1 transcript is required for genomic imprinting of neighboring genes. Genes Dev 20 (2006), 1268–1282.
29. Lee, J.T., Epigenetic regulation by long noncoding RNAs. Science 338 (2012), 1435–1439.
30. Guil, S., Esteller, M., Cis-acting noncoding RNAs: friends and foes. Nat Struct Mol Biol 19 (2012), 1068–1075.
31. Oberle, I., Rousseau, F., Heitz, D., et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252 (1991), 1097–1102.
32. Latos, P.A., Pauler, F.M., Koerner, M.V., et al. Airn transcriptional overlap, but not its lncRNA products, induces imprinted Igf2r silencing. Science 338 (2012), 146914–146972.
33. Schmitt, A.M., Garcia, J.T., Hung, T., et al. An inducible long noncoding RNA amplifies DNA damage signaling. Nat Genet 48 (2016), 1370–1376.
34. Schlackow, M., Nojima, T., Gomes, T., et al. Distinctive patterns of transcription and RNA processing for human lincRNAs. Mol Cell 65 (2017), 25–38.
35. Hibi, K., Nakamura, H., Hirai, A., et al. Loss of H19 imprinting in esophageal cancer. Cancer Res 56 (1996), 480–482.
36. Moore, T., Haig, D., Genomic imprinting in mammalian development: a parental tug-of-war. Trends Genet 7 (1991), 45–49.
37. Leighton, P.A., Saam, J.R., Ingram, R.S., et al. An enhancer deletion affects both H19 and Igf2 expression. Genes Dev 9 (1995), 2079–2089.
38. Luo, H.L., Huang, M.D., Guo, J.N., et al. AFAP1-AS1 is upregulated and promotes esophageal squamous cell carcinoma cell proliferation and inhibits cell apoptosis. Cancer Med 5 (2016), 2879–2885.
39. Yao, W., Bai, Y., Li, Y., et al. Upregulation of MALAT-1 and its association with survival rate and the effect on cell cycle and migration in patients with esophageal squamous cell carcinoma. Tumour Biol 37 (2016), 4305–4312.
40. Zhang, X., Xu, Y., He, C., et al. Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol 111 (2015), 834–839.
41. Hu, L., Wu, Y., Tan, D., et al. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma. J Exp Clin Cancer Res, 34, 2015, 7.
42. Wei, G., Luo, H., Sun, Y., et al. Transcriptome profiling of esophageal squamous cell carcinoma reveals a long noncoding RNA acting as a tumor suppressor. Oncotarget 6 (2015), 17065–17080.
43. Wang, X., Li, M., Wang, Z., et al. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. J Biol Chem 290 (2015), 3925–3935.
44. Chen, F.J., Sun, M., Li, S.Q., et al. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol Carcinog 52 (2013), 908–915.
45. Yan, X., Hu, Z., Feng, Y., et al. Comprehensive genomic characterization of long non-coding RNAs across human cancers. Cancer Cell 28 (2015), 529–540.
46. Wu, W., Bhagat, T.D., Yang, X., et al. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 144 (2013), 956–966.e4.
47. Qian, Y., Gatesman, A.S., Baisden, J.M., et al. Analysis of the role of the leucine zipper motif in regulating the ability of AFAP-110 to alter actin filament integrity. J Cell Biochem 91 (2004), 602–620.
48. Baisden, J.M., Gatesman, A.S., Cherezova, L., et al. The intrinsic ability of AFAP-110 to alter actin filament integrity is linked with its ability to also activate cellular tyrosine kinases. Oncogene 20 (2001), 6607–6616.
49. Huang, C., Yu, Z., Yang, H., et al. Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients. Biomed Pharmacother 83 (2016), 8–13.
50. Pan, Z., Mao, W., Bao, Y., et al. The long noncoding RNA CASC9 regulates migration and invasion in esophageal cancer. Cancer Med 5 (2016), 2442–2447.
51. Huang, B., Song, J.H., Cheng, Y., et al. Long non-coding antisense RNA KRT7-AS is activated in gastric cancers and supports cancer cell progression by increasing KRT7 expression. Oncogene 35 (2016), 4927–4936.
52. Yang, X., Song, J.H., Cheng, Y., et al. Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut 63 (2014), 881–890.
53. Li, S., Xu, Y., Sun, Z., et al. Identification of a lncRNA involved functional module for esophageal cancer subtypes. Mol Biosyst 12 (2016), 3312–3323.
54. Tong, Y.S., Wang, X.W., Zhou, X.L., et al. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Mol Cancer, 14, 2015, 3.
55. Hu, H.B., Jie, H.Y., Zheng, X.X., Three circulating lncRNA predict early progress of esophageal squamous cell carcinoma. Cell Physiol Biochem 40 (2016), 117–125.
56. Bejerano, G., Pheasant, M., Makunin, I., et al. Ultraconserved elements in the human genome. Science 304 (2004), 1321–1325.
57. Esteller, M., Non-coding RNAs in human disease. Nat Rev Genet 12 (2011), 861–874.
58. Baira, E., Greshock, J., Coukos, G., et al. Ultraconserved elements: genomics, function and disease. RNA Biol 5 (2008), 132–134.
59. Calin, G.A., Liu, C.G., Ferracin, M., et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 12 (2007), 215–229.
60. Wojcik, S.E., Rossi, S., Shimizu, M., et al. Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer. Carcinogenesis 31 (2010), 208–215.
61. Shen, H., Lu, C., Jiang, Y., et al. Genetic variants in ultraconserved elements and risk of breast cancer in Chinese population. Breast Cancer Res Treat 128 (2011), 855–861.
62. Yang, R., Frank, B., Hemminki, K., et al. SNPs in ultraconserved elements and familial breast cancer risk. Carcinogenesis 29 (2008), 351–355.
63. Fassan, M., Dall'Olmo, L., Galasso, M., et al. Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis. Oncotarget 5 (2014), 7162–7171.
64. Ingravallo, G., Dall'Olmo, L., Segat, D., et al. CDX2 hox gene product in a rat model of esophageal cancer. J Exp Clin Cancer Res, 28, 2009, 108.
65. Braconi, C., Valeri, N., Kogure, T., et al. Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc Natl Acad Sci U S A 108 (2011), 786–791.
66. Lujambio, A., Portela, A., Liz, J., et al. CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene 29 (2010), 6390–6401.
67. Paparidis, Z., Abbasi, A.A., Malik, S., et al. Ultraconserved non-coding sequence element controls a subset of spatiotemporal GLI3 expression. Dev Growth Differ 49 (2007), 543–553.
68. Jin, Y., Jin, C., Law, S., et al. Cytogenetic and fluorescence in situ hybridization characterization of clonal chromosomal aberrations and CCND1 amplification in esophageal carcinomas. Cancer Genet Cytogenet 148 (2004), 21–28.
69. Paulson, T.G., Maley, C.C., Li, X., et al. Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res 15 (2009), 3305–3314.
70. Zaninotto, G., Minnei, F., Guirroli, E., et al. The Veneto Region's Barrett's Oesophagus Registry: aims, methods, preliminary results. Dig Liver Dis 39 (2007), 18–25.
71. Morales, C.P., Lee, E.L., Shay, J.W., In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer 83 (1998), 652–659.
72. Lord, R.V., Salonga, D., Danenberg, K.D., et al. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg 4 (2000), 135–142.
73. Souza, R.F., Lunsford, T., Ramirez, R.D., et al. GERD is associated with shortened telomeres in the squamous epithelium of the distal esophagus. Am J Physiol Gastrointest Liver Physiol 293 (2007), G19–G24.
74. Merchant, N.B., Dutta, S.K., Girotra, M., et al. Evidence for enhanced telomerase activity in Barrett's esophagus with dysplasia and adenocarcinoma. Asian Pac J Cancer Prev 14 (2013), 679–683.